Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

May 01, 2010; Volume 38,Issue 5

Short Communications

  • You have access
    Metabolism of 17α-Hydroxyprogesterone Caproate, an Agent for Preventing Preterm Birth, by Fetal Hepatocytes
    Shringi Sharma, Ewa C. S. Ellis, Kenneth Dorko, Shimin Zhang, Donald R. Mattison, Steve N. Caritis, Raman Venkataramanan and Stephen C. Strom
    Drug Metabolism and Disposition May 2010, 38 (5) 723-727; DOI: https://doi.org/10.1124/dmd.109.029918
  • You have access
    Inhibition of Morphine Metabolism by Ketamine
    Xiaoxin Qi, Allan M. Evans, Jiping Wang, John O. Miners, Richard N. Upton and Robert W. Milne
    Drug Metabolism and Disposition May 2010, 38 (5) 728-731; DOI: https://doi.org/10.1124/dmd.109.030957
  • You have access
    Engineering Bacterial Cytochrome P450 (P450) BM3 into a Prototype with Human P450 Enzyme Activity Using Indigo Formation
    Sun-Ha Park, Dong-Hyun Kim, Dooil Kim, Dae-Hwan Kim, Heung-Chae Jung, Jae-Gu Pan, Taeho Ahn, Donghak Kim and Chul-Ho Yun
    Drug Metabolism and Disposition May 2010, 38 (5) 732-739; DOI: https://doi.org/10.1124/dmd.109.030759

Articles

  • You have access
    Breast Cancer Resistance Protein (BCRP)-Mediated Glyburide Transport: Effect of the C421A/Q141K BCRP Single-Nucleotide Polymorphism
    Erika K. Pollex, Gregory Anger, Janine Hutson, Gideon Koren and Micheline Piquette-Miller
    Drug Metabolism and Disposition May 2010, 38 (5) 740-744; DOI: https://doi.org/10.1124/dmd.109.030791
  • You have access
    Functional Characterization of Cytochrome P450 2A6 Allelic Variants CYP2A6*15, CYP2A6*16, CYP2A6*21, and CYP2A6*22
    Kai Hung Tiong, Beow Chin Yiap, Eng Lai Tan, Rusli Ismail and Chin Eng Ong
    Drug Metabolism and Disposition May 2010, 38 (5) 745-751; DOI: https://doi.org/10.1124/dmd.109.031054
  • You have access
    Formation and Distribution of NNK Metabolites in an Isolated Perfused Rat Lung
    Laura A. Maertens, Pramod Upadhyaya, Stephen S. Hecht and Cheryl L. Zimmerman
    Drug Metabolism and Disposition May 2010, 38 (5) 752-760; DOI: https://doi.org/10.1124/dmd.109.031492
  • You have access
    Cytochrome P450 1A2 Detoxicates Aristolochic Acid in the Mouse
    Thomas A. Rosenquist, Heidi J. Einolf, Kathleen G. Dickman, Lai Wang, Amanda Smith and Arthur P. Grollman
    Drug Metabolism and Disposition May 2010, 38 (5) 761-768; DOI: https://doi.org/10.1124/dmd.110.032201
  • You have access
    Interplay of Phase II Enzymes and Transporters in Futile Cycling: Influence of Multidrug Resistance-Associated Protein 2-Mediated Excretion of Estradiol 17β-d-Glucuronide and Its 3-Sulfate Metabolite on Net Sulfation in Perfused TR− and Wistar Rat Liver Preparations
    Huadong Sun, Ying-Ying Zeng and K. Sandy Pang
    Drug Metabolism and Disposition May 2010, 38 (5) 769-780; DOI: https://doi.org/10.1124/dmd.109.029959
  • You have access
    Mild Hypothermia Alters Midazolam Pharmacokinetics in Normal Healthy Volunteers
    David Hostler, Jiangquan Zhou, Michael A. Tortorici, Robert R. Bies, Jon C. Rittenberger, Philip E. Empey, Patrick M. Kochanek, Clifton W. Callaway and Samuel M. Poloyac
    Drug Metabolism and Disposition May 2010, 38 (5) 781-788; DOI: https://doi.org/10.1124/dmd.109.031377
  • You have access
    Excretion and Metabolism of Lersivirine (5-{[3,5-Diethyl-1-(2-hydroxyethyl)(3,5-14C2)-1H-pyrazol-4-yl]oxy}benzene-1,3-dicarbonitrile), a Next-Generation Non-Nucleoside Reverse Transcriptase Inhibitor, after Administration of [14C]Lersivirine to Healthy Volunteers
    Manoli Vourvahis, Michelle Gleave, Angus N. R. Nedderman, Ruth Hyland, Iain Gardner, Martin Howard, Sarah Kempshall, Claire Collins and Robert LaBadie
    Drug Metabolism and Disposition May 2010, 38 (5) 789-800; DOI: https://doi.org/10.1124/dmd.109.031252
  • You have access
    In Vitro Metabolism and Identification of Human Enzymes Involved in the Metabolism of Methylnaltrexone
    Zeen Tong, Appavu Chandrasekaran, Hongshan Li, Yakov Rotshteyn, John C. L. Erve, William DeMaio, Rasmy Talaat, Theresa Hultin and JoAnn Scatina
    Drug Metabolism and Disposition May 2010, 38 (5) 801-807; DOI: https://doi.org/10.1124/dmd.110.032169
  • You have access
    Pharmacokinetics, Metabolism, and Disposition of Deferasirox in β-Thalassemic Patients with Transfusion-Dependent Iron Overload Who Are at Pharmacokinetic Steady State
    Felix Waldmeier, Gerard J. Bruin, Ulrike Glaenzel, Katharine Hazell, Romain Sechaud, Steve Warrington and John B. Porter
    Drug Metabolism and Disposition May 2010, 38 (5) 808-816; DOI: https://doi.org/10.1124/dmd.109.030833
  • You have access
    Sex-Dependent Differences in Cytochrome P450 3A Activity as Assessed by Midazolam Disposition in Humans: A Meta-Analysis
    Zhe-Yi Hu and Yuan-Sheng Zhao
    Drug Metabolism and Disposition May 2010, 38 (5) 817-823; DOI: https://doi.org/10.1124/dmd.109.031328
  • You have access
    Metabolism of 2,6-Dichloro-4-(3,3-dichloroallyloxy)phenyl 3-[5-(trifluoromethyl)-2-pyridyloxy]propyl Ether (Pyridalyl) in Rats after Repeated Oral Administration and a Simple Physiologically Based Pharmacokinetic Modeling in Brown and White Adipose Tissues
    Hirohisa Nagahori, Haruyuki Matsunaga, Yoshitaka Tomigahara, Naohiko Isobe and Hideo Kaneko
    Drug Metabolism and Disposition May 2010, 38 (5) 824-832; DOI: https://doi.org/10.1124/dmd.109.031914
  • You have access
    Pharmacokinetics of Metformin during Pregnancy
    Sara Eyal, Thomas R. Easterling, Darcy Carr, Jason G. Umans, Menachem Miodovnik, Gary D. V. Hankins, Shannon M. Clark, Linda Risler, Joanne Wang, Edward J. Kelly, Danny D. Shen and Mary F. Hebert
    Drug Metabolism and Disposition May 2010, 38 (5) 833-840; DOI: https://doi.org/10.1124/dmd.109.031245
  • You have access
    Bioactivation of a Novel 2-Methylindole-Containing Dual Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type-2 Cells/d-Prostanoid Receptor Antagonist Leads to Mechanism-Based CYP3A Inactivation: Glutathione Adduct Characterization and Prediction of In Vivo Drug-Drug Interaction
    Simon G. Wong, Peter W. Fan, Raju Subramanian, George R. Tonn, Kirk R. Henne, Michael G. Johnson, Michelle Tadano Lohr and Bradley K. Wong
    Drug Metabolism and Disposition May 2010, 38 (5) 841-850; DOI: https://doi.org/10.1124/dmd.109.031344
  • You have access
    Use of the Entero-Test, a Novel Approach for the Noninvasive Capture of Biliary Metabolites in Dogs
    W. J. Guiney, C. Beaumont and S. R. Thomas
    Drug Metabolism and Disposition May 2010, 38 (5) 851-856; DOI: https://doi.org/10.1124/dmd.109.031062
  • You have access
    Chlorzoxazone Metabolism by Porcine Cytochrome P450 Enzymes and the Effect of Cytochrome b5
    P. Wiercinska and E. J. Squires
    Drug Metabolism and Disposition May 2010, 38 (5) 857-862; DOI: https://doi.org/10.1124/dmd.109.030528
  • You have access
    Role of Human UGT2B10 in N-Glucuronidation of Tricyclic Antidepressants, Amitriptyline, Imipramine, Clomipramine, and Trimipramine
    Diansong Zhou, Jian Guo, Alban J. Linnenbach, Catherine L. Booth-Genthe and Scott W. Grimm
    Drug Metabolism and Disposition May 2010, 38 (5) 863-870; DOI: https://doi.org/10.1124/dmd.109.030981
  • You have access
    Metabolism-Mediated Drug Interactions Associated with Ritonavir-Boosted Tipranavir in Mice
    Feng Li, Laiyou Wang, Grace L. Guo and Xiaochao Ma
    Drug Metabolism and Disposition May 2010, 38 (5) 871-878; DOI: https://doi.org/10.1124/dmd.109.030817
  • You have access
    A Humanized UGT1 Mouse Model Expressing the UGT1A1*28 Allele for Assessing Drug Clearance by UGT1A1-Dependent Glucuronidation
    Hongliang Cai, Nghia Nguyen, Vincent Peterkin, Young-Sun Yang, Kathy Hotz, Deirdre Beaton La Placa, Shujuan Chen, Robert H. Tukey and Jeffrey C. Stevens
    Drug Metabolism and Disposition May 2010, 38 (5) 879-886; DOI: https://doi.org/10.1124/dmd.109.030130

Erratum

  • You have access
    Correction to “In Vitro Assessment of Metabolic Drug-Drug Interaction Potential of Apixaban through Cytochrome P450 Phenotyping, Inhibition, and Induction Studies”
    Drug Metabolism and Disposition May 2010, 38 (5) 887; DOI: https://doi.org/10.1124/dmd.109.000019
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 38 (5)
Drug Metabolism and Disposition
Vol. 38, Issue 5
1 May 2010
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Short Communications
  • Articles
  • Erratum
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics